Skip to main content
. 2019 Jul 19;9:37. doi: 10.1186/s13601-019-0272-9

Table 2.

Select comorbid conditions at baseline and follow-up

Comorbid conditions, n (%) Baseline Follow-up
Elderly (≥ 65 years) Younger (< 65 years) P Elderly (≥ 65 years) Younger (< 65 years) P
Bleeding 4 (4.0) 5 (0.6) 0.0130 4 (4.0) 5 (0.6) 0.0130
Cardiovascular/cerebrovascular 50 (50) 69 (8.9)  < 0.0001 26 (26.0) 49 (6.3) <0.0001
Diabetes 11 (11.0) 17 (2.2) 0.0001 6 (6.0) 8 (1.0) 0.0027
Gastrointestinal 11 (11.0) 19 (2.5) 0.0002 7 (7.0) 24 (3.1) 0.0757
Hepatic 1 (1.0) 0 (0.0) 0.1147 2 (2.0) 1 (0.1) 0.0362
Immunological 2 (2.0) 25 (3.2) 0.7592 2 (2.0) 36 (4.7) 0.3008
Infections 1 (1.0) 8 (1.0) 1.0000 4 (4.0) 25 (3.2) 0.5650
Neoplasia 3 (3.0) 6 (0.08) 0.0735 0 (0.0) 2 (0.3) 1.0000
Neurological 1 (1.0) 9 (1.2) 1.0000 3 (3.0) 9 (1.2) 0.1498
Osteoarticular 1 (1.0) 7 (0.9) 1.0000 2 (2.0) 17 (2.2) 1.0000
Psychiatric 7 (7.0) 23 (3.0) 0.0706 6 (6.0) 25 (3.2) 0.1549
Pulmonary 7 (7.0) 11 (1.4) 0.0023 2 (2.0) 10 (1.3) 0.6380
Renal/urogenital 4 (4.0) 5 (0.6) 0.0130 3 (3.0) 6 (0.8) 0.0735